Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹19.05Admitted-Finance | L1 | Admitted-Finance | |
| 2 | L2₹39.31+₹20.26 (106.4%)Admitted-Finance | L2 | Admitted-Finance | |
| 3 | L3₹47.04+₹27.99 (146.9%)Admitted-Finance | L3 | Admitted-Finance | |
| 4 | L4₹56.14+₹37.09 (194.7%)Admitted-Finance PLOT NO 208 KISHANPUR ROORKEE HARIDWAR UTTARAKHAND INDIA 247667 | ROORKEE | HARIDWAR | UTTARAKHAND | 247667 | L4 | Admitted-Finance | |
| 5 | L5₹57.12+₹38.07 (199.8%)Admitted-Finance | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Synokem Pharmaceuticals Limited L13 | MSN Laboratories Private Limited L11 | REGENT AJANTA BIOTECH L9 | salud Care (I) Pvt. Ltd L6 | UNICURE INDIA LIMITED L12 | CMG BIOTECH PVT LTD L10 | MICRON PHARMACEUTICALS L16 | Apple formulations Pvt. Ltd L4 | Centurion Remedies Pvt. Ltd L17 | MESMER PHARMACEUTICALS L2 | Ravian Life Science Pvt Ltd L1 | HEALTH BIOTECH LTD L7 | J.Duncan Healthcare Pvt. Ltd. L15 | RELIANCE FORMULATION PVT. LTD L8 | BIODEAL PHARMACEUTICALS PVT. LTD. L3 | Bharat Parenterals Ltd. L14 | Macleods Pharmaceuticals Ltd. L5 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00Drug/Medicine details: | ||||||||||||||||||||
| 2.00 | Thyroxine Sodium Tablets IP 25mcg | 30,00,000 | 100's Bottle | - | - | - | - | 29.29 ₹32.8 | - | - | - | 29.97 ₹33.57 | - | - | - | - | - | 19.8 ₹22.18 Lowest | - | 24 ₹26.88 |
| 3.00 | Thyroxine Sodium Tablets IP 75mcg | 30,00,000 | 100's Bottle | - | - | - | - | 38.38 ₹42.99 | - | - | - | 36.99 ₹41.43 | - | - | - | - | - | 22.2 ₹24.86 Lowest | - | 27 ₹30.24 |
| 4.00 | Disodium Hydrogen Citrate Syrup 1.53gm per 5ml | 3,00,000 | 100ml Bottle | 25.25 ₹28.28 | - | - | - | 14.5 ₹16.24 Lowest | - | - | 15.96 ₹17.88 | - | - | - | - | - | - | - | - | - |
| 5.00 | Citric Acid 334mg and Potassium Citrate 1100mg Syrup per 5ml | 3,00,000 | 200ml Bottle | - | - | 37.92 ₹42.47 | 36.23 ₹40.58 | 22.22 ₹24.89 Lowest | - | - | 34.16 ₹38.26 | - | - | - | - | - | - | - | - | - |
| 6.00 | Darifenacin Prolonged Release Tablets IP 7.5mg | 15,00,000 | 10's | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 7.00 | Solifenacin Succinate Tablets IP 5 mg | 3,00,000 | 10's | - | 51.8 ₹58.02 | 9.05 ₹10.14 Lowest | - | - | 28.4 ₹31.81 | - | - | - | - | - | - | - | - | - | - | - |
| 8.00 | Solifenacin Succinate Tablets IP 10 mg | 15,00,000 | 10's | - | 102.8 ₹115.14 | 17.15 ₹19.21 Lowest | - | - | 44.9 ₹50.29 | - | - | - | - | - | - | - | - | - | - | - |
| 9.00 | Brinzolamide Ophthalmic Suspension IP 1% w/v | 3,60,000 | 5ml Drops | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 10.00 | Bromfenac 0.09% w/v and Moxifloxacin 0.5% w/v Eye Drops | 3,60,000 | 5ml Drops | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Tender Value
₹500 Cr
Closing Date
12 Apr 2022, 5:00 pmClosed
As per Tender Document
As per Tender Document
e-Tender for Rate contract for the supply of drugs to Pharmaceuticals and Medical Devices Bureau of India (PMBI)
2022_BPPI_679074_1
PMBI/DRUG/RC-192/2022
Open Tender
Drugs and Pharmaceutical Products
Item Rate
45 days
As per Tender Document
Please refer Tender documents.
3 documents required · 3 mandatory
₹0
Exempted
As per Tender Document
31 May 2022
15 Mar 2022
19 Apr 2022
15 Mar 2022
12 Apr 2022
21 Mar 2022
15 Mar 2022 - 21 Mar 2022
22 Mar 2022
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Drug/Medicine details: | - | - | - | - |
| 2 | Thyroxine Sodium Tablets IP 25mcg | 30,00,000 | 100's Bottle | - | - |
| 3 | Thyroxine Sodium Tablets IP 75mcg | 30,00,000 | 100's Bottle | - | - |
| 4 | Disodium Hydrogen Citrate Syrup 1.53gm per 5ml | 3,00,000 | 100ml Bottle | - | - |
| 5 | Citric Acid 334mg and Potassium Citrate 1100mg Syrup per 5ml | 3,00,000 | 200ml Bottle | - | - |
| 6 | Darifenacin Prolonged Release Tablets IP 7.5mg | 15,00,000 | 10's | - | - |
| 7 | Solifenacin Succinate Tablets IP 5 mg | 3,00,000 | 10's | - | - |
| 8 | Solifenacin Succinate Tablets IP 10 mg | 15,00,000 | 10's | - | - |
| 9 | Brinzolamide Ophthalmic Suspension IP 1% w/v | 3,60,000 | 5ml Drops | - | - |
| 10 | Bromfenac 0.09% w/v and Moxifloxacin 0.5% w/v Eye Drops | 3,60,000 | 5ml Drops | - | - |
stage.html
html • 0.06 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.23 MB
Tenderdocument192.pdf
Tender Documents • 1.44 MB
NIT192.pdf
Additional Documents • 0.22 MB
BOQ_714638.xls
BOQ • 0.37 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .